Ichthyosis Support Group Competitors

Johns Hopkins Medicine is a governing structure for the University’s School of Medicine and the health system, coordinating their research, teaching, patient care, and related enterprises. The Johns Hopkins Hospital opened in 1889, followed four years later by the university’s School of Medicine, revolutionizing medical practice, teaching, and research in the United States. The hospital is now part of the Johns Hopkins Health System, which includes two other acute-care hospitals and additional integrated health-care delivery components, with a network of primary and specialty care practices throughout Maryland, outpatient care, long-term care, and home care. The Johns Hopkins University opened in 1876 as America’s first research university, founded for the express purpose of expanding knowledge and putting that knowledge to work for the good of humanity. Two Interconnected Institutions: Over the years, the University and Hospital have grown, and—sometimes jointly, sometimes separately—they have created affiliated organizations. The Johns Hopkins Institutions is a collective name for the University and the Johns Hopkins Health System. The Johns Hopkins University includes nine academic and research divisions, and numerous centers, institutes, and affiliated entities. Johns Hopkins Medicine is a governing structure for the University’s School of Medicine and the health system, coordinating their research, teaching, patient care, and related enterprises.

The American Academy of Dermatology is a non-profit medical specialty association founded in 1938. The work we do on behalf of our members, their patients, and the public is guided by our mission to promote leadership in dermatology and excellence in patient care through education, research and advocacy. With over 200 employees, we support the largest, most influential and representative dermatology group in the United States. With a membership of more than 20,500, the AAD represents virtually all practicing dermatologists in the United States, as well as a growing number of international dermatologists. The AAD is committed to advancing the diagnosis and medical, surgical, and cosmetic treatment of the skin, hair, and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin. The American Academy of Dermatology Association is the sister organization to the AAD, and is the resource for government affairs as well as health policy and practice information for dermatologists. It plays a major role in formulating policies that can enhance the quality of dermatologic care. Specialty: Promoting leadership in dermatology and excellence in patient care through education, research and advocacy. Website: http://www.aad.org/ Industry: Nonprofit Organization Management Type: Nonprofit Headquarters: Rosemont, IL United States Company Size: 51-200 employees Founded: 1938 To learn more about the Academy please visit our website at www.aad.org, or follow us on these social media outlets: - Facebook (www.facebook.com/aadskin) - Twitter (www.twitter.com/AADskin) - Pinterest (www.pinterest.com/AADskin) - Instagram (www.instagram.com/aadskin1) - GlassDoor: https://www.glassdoor.com/Overview/Working-at-American-Academy-of-Dermatology-EI_IE366697.11,42.htm

The National Organization for Rare Disorders (NORD), a 501(c)(3) organization, is an independent patient advocacy organization dedicated to helping individuals with rare diseases and the organizations that serve them. NORD, along with its 350+ patient organization members, is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient support services. NORD serves all stakeholders in the rare disease community, including patients and their families, patient organizations, researchers, medical professionals, medical students, and companies developing orphan products. NORD also works closely with many government agencies, most notably the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). All NORD programs are focused on one ultimate goal: to improve the lives of individuals and families affected by rare diseases. NORD is the official U.S. sponsor of Rare Disease Day, an international observance day held on the last day of February each year. Its goals are to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families. To learn more, visit rarediseases.org/rare-disease-day. To learn more, please visit the NORD website at www.rarediseases.org. You can also follow NORD on X at @RareDiseases.